The objective of the legislation is to diminish stigma and enhance social inclusion and support for individuals grappling with mental illness. Additionally, it includes provisions designed to enhance outcomes and safeguard the rights of those experiencing mental health challenges.
The Mental Healthcare Act of 2017 incorporates the following provisions:
Cerletti and Bini pioneered the utilization of electroconvulsive therapy (ECT) as a treatment method.
Informed Consent: While the conditions that typically respond to Electroconvulsive Therapy (ECT) primarily impact mental well-being, it is imperative, for both legal and ethical considerations, that patients comprehend the potential risks and benefits of ECT before consenting to the procedure. If a patient is unable to provide informed consent, clinicians must adhere to the legal requirements of the state for alternative methods of obtaining permission.
Precautions:
Following the administration of general anesthesia, a seizure is induced by applying an electric current to the brain through either unilateral or bilateral electrodes on the forehead.
Advantages of Methohexital as an Anesthetic in ECT (compared to other barbiturates):
Caution should be exercised when concurrently using Electroconvulsive Therapy (ECT) and each class of psychoactive medications.
This therapy entails the induction of generalized seizures, with the effectiveness of the treatment being optimal when the seizures last for a minimum of 25 seconds. Following each session, the patient is roused. This process is then replicated two to three times weekly, accumulating to a total of 6 to 12 treatments.
The positioning of electrodes on the head plays a crucial role in determining the outcome. The two frequently employed positions are bilateral and unilateral, as illustrated below.
The induction of seizures is believed to bring about alterations in neurotransmitter receptors and secondary messenger systems within the brain, producing effects akin to those observed with antidepressant medications. ECT induces an elevation in Brain-derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) in the hippocampus.
Electroconvulsive therapy stands out as one of the safest and most efficacious treatments for depression, gaining broader acceptance with the incorporation of modern anesthetics. Apart from obtaining informed consent, the procedure necessitates comprehensive medical clearance. Particularly for elderly individuals who struggle with tolerating antidepressants or face contraindications to their use, ECT often emerges as a crucial treatment option. While there are no absolute contraindications to ECT, caution is advised for patients with elevated intracranial pressure, unstable angina, recent myocardial infarction, and electrolyte imbalances. Notably, the mortality rate aligns with that linked to general anesthesia. Electroconvulsive therapy involves the induction of seizures through electrical means, offering relief from mental disorders.
Single most coomon Indication for ECT is Depression
When should electroconvulsive therapy (ECT) be considered for depression?
Other indications
Side Effects
Note: Memory disturbances typically resolve within 1-6 months, and the procedure is considered safe during pregnancy.
There are no absolute contraindications to ECT
Relative contraindications:
Electro Convulsive Therapy - Repeats
7 videos|219 docs
|
1. What is the Mental Healthcare Act 2017 and what does it entail? |
2. What is Electroconvulsive Therapy (ECT) and how is it regulated under the Mental Healthcare Act 2017? |
3. What are some frequently asked questions about the Mental Healthcare Act 2017? |
4. Can a person be forced to undergo Electroconvulsive Therapy (ECT) under the Mental Healthcare Act 2017? |
5. What are the guidelines for the administration of Electroconvulsive Therapy (ECT) under the Mental Healthcare Act 2017? |
|
Explore Courses for UPSC exam
|